Intellectual and developmental disabilities (IDD) and cancer symptom reporting: a matched retrospective cohort study
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-025-09620-5 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Rachel Giblon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Intellectual Disability, Neoplasms, Developmental Disabilities, Symptom Assessment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: CIHR, Canadian Cancer Society, Canadian Institutes of Health Research.
Abstract (Originalsprache)
PURPOSE: Symptom assessment is key to managing symptom burden following a cancer diagnosis. Adults with intellectual or developmental disabilities (IDD) experience worse outcomes from cancer; disparities may also exist in routine cancer symptom screening. This study investigated whether differences exist in routine cancer symptom assessment between people with and without IDD in a public healthcare system. METHODS: We conducted a matched retrospective cohort study of adults in Ontario, Canada, with and without IDD who received a cancer diagnosis between 2010 and 2019 using administrative health data. Among people with cancer, those with IDD were hard-matched 1:5 to those without IDD on age at diagnosis, sex, diagnosis year, cancer type and regional cancer centre registration. Cumulative incidence of first symptom assessment accounting for death as a competing risk was estimated. Sub-distribution and cause-specific hazards models were used. Effect modification by age, sex and cancer stage was investigated. RESULTS: A total of 1545 people with IDD were matched to 7725 people without IDD. Individuals with IDD experienced a lower incidence of cancer symptom assessment (1-year probability: 0.62 vs. 0.77) and lower rates of symptom assessment (sub-distribution HR: 0.63, 95% CI: 0.59, 0.67; cause-specific HR: 0.69, 95% CI: 0.65, 0.73) relative to those without IDD. Results were most pronounced for those in advanced cancer stages. CONCLUSION: Among persons with cancer, the incidence of symptom assessment is lower for individuals with IDD compared to those without; the magnitude of these findings varied across cancer stages. These findings may indicate systemic barriers to equitable healthcare access for people with cancer and IDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
- ICES, Toronto, ON, Canada. alyson.mahar@queensu.ca.
- School of Nursing, Queen's University, Kingston, ON, Canada. alyson.mahar@queensu.ca.
- ICES, Toronto, ON, Canada.
- Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
- Department of Surgery, Sunnybrook Health Sciences Center, Toronto, ON, Canada.
Förderung
- CIHR
- Canadian Cancer Society
- Canadian Institutes of Health Research
Zitieren
APA
Giblon, R., Mahar, A., Hallet, J., Kelly, C., Coburn, N., Shooshtari, S., & Sutradhar, R. (2025). Intellectual and developmental disabilities (IDD) and cancer symptom reporting: a matched retrospective cohort study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09620-5
Vancouver
Giblon R, Mahar A, Hallet J, Kelly C, Coburn N, Shooshtari S, et al. Intellectual and developmental disabilities (IDD) and cancer symptom reporting: a matched retrospective cohort study. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09620-5
BibTeX
@article{Giblon2025,
author = {Giblon, Rachel and Mahar, Alyson and Hallet, Julie and Kelly, Christine and Coburn, Natalie and Shooshtari, Shahin and Sutradhar, Rinku},
title = {Intellectual and developmental disabilities (IDD) and cancer symptom reporting: a matched retrospective cohort study},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-025-09620-5}
}
EUVIMED